JF
MCRB icon

Jump Financial’s Seres Therapeutics MCRB Stock Holding History

Jump Financial’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-512
Closed -$7.41K – 1931
2024
Q2 		$7.41K Buy
+512
New +$8.54K ﹤0.01% 1736
2023
Q3 		– Sell
-1,126
Closed -$108K – 2095
2023
Q2 		$108K Buy
+1,126
New +$123K ﹤0.01% 1643
2023
Q1 		– Sell
-3,657
Closed -$410K – 1858
2022
Q4 		$410K Buy
+3,657
New +$490K 0.02% 866
2022
Q1 		– Sell
-1,324
Closed -$221K – 1752
2021
Q4 		$221K Buy
+1,324
New +$210K 0.01% 1062
2021
Q3 		– Sell
-2,378
Closed -$1.13M – 1335
2021
Q2 		$1.13M Buy
2,378
+1,015
+74% +$428K 0.11% 244
2021
Q1 		$561K Sell
1,363
-747
-35% -$344K 0.05% 371
2020
Q4 		$1.03M Buy
+2,110
New +$1.24M 0.18% 150

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Jump Financial's MCRB Position: Q3 2024 in Review

Jump Financial sold out of Seres Therapeutics (MCRB) in Q3 2024, closing a stake of 512 shares — an estimated $7.41K sold.

Jump Financial first reported a position in MCRB in Q4 2020 and held it in 7 quarters. The position peaked at $1.13M in Q2 2021. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2024.

  • Jump Financial reported no remaining Seres Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 512 Seres Therapeutics shares in Q3 2024, an estimated $7.41K.
  • Jump Financial first reported a position in Seres Therapeutics in Q4 2020 and held it in 7 quarters.
  • Jump Financial's Seres Therapeutics position peaked at $1.13M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.